Pricing
  1. JP-listed companies
  2. MIZUHO MEDY CO.,LTD.
  3. Financials
  4. Revenue

MIZUHO MEDY CO.,LTD. (4595)

Market cap
¥34.5B
P/E ratio
10.7x
Mizuho Medic develops and manufactures diagnostic test kits for hospitals and consumers, specializing in infectious disease testing including COVID-19 and influenza.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Dec 31, 202511,260-1.48%
Dec 31, 202411,429+4.00%
Dec 31, 202310,990-37.49%
Dec 31, 202217,582+33.83%
Dec 31, 202113,137+212.39%
Dec 31, 20204,205-34.57%
Dec 31, 20196,428+0.06%
Dec 31, 20186,424+14.21%
Dec 31, 20175,625+13.36%
Dec 31, 20164,962+21.54%
Dec 31, 20154,082+2.39%
Dec 31, 20143,987+22.75%
Dec 31, 20133,248+2.04%
Dec 31, 20123,183+10.91%
Dec 31, 20112,870

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat